Clinical Trials Staff

Tarek Alhamad, MD, MS, FACP, FASN, Medical Director, Pancreas Transplant Interim Medical Director, Kidney Transplant Program

Dr. Alhamad’s clinical focus is on Antibody mediated rejection, simultaneous pancreas and kidney transplantation, high risk kidney transplantation, recurrent glomerulonephritis. His research interests include simultaneous pancreas and kidney transplantation, donation after cardiac death, immunosuppression minimization.

Daniel W. Coyne, MD, Professor of Medicine
Director, Medical Multispecialty Outpatient Group, CAM
Director of Hemodialysis, Chromalloy American Kidney Center

My clinical interests include providing comprehensive care to patients with chronic kidney disease (CKD), hypertension, proteinuria, glomerular diseases, inherited kidney diseases, fluid and electrolyte disorders, and care for patients requiring chronic dialysis. Dr. Coyne also participates in research, with focus on anemia and renal bone disease, problems commonly seen among patients with CKD. My anemia research has focused on the proper use of epoetin and similar drugs, the role of iron in proper management, and defining the significant clinical risks and limited benefits of aggressive treatment of anemia in CKD. My research has also explored the value of treatments for renal metabolic bone disease, also known as CKD-MBD. Studies have included human trials of paricalcitol, cinacalcet, ergocalciferol, niacinamide, and various phosphate binders.

Rowena Delos Santos, MD, Assistant Professor of Medicine, Transplant

In her clinical work with patients, Dr. Delos Santos’ interests cover pancreas and kidney transplant and ABO incompatible transplants, immunosuppression management, infectious complications in transplantation, treatment and prevention of transplant rejection and recurrence of primary renal diseases in the transplanted kidney.

Dr. Delos Santos also conducts research with interests in transplant outcomes-cardiovascular and infectious complications, transplant rejection and recurrence of primary diseases in the transplanted population. Additional work as a site investigator investigates medications and treatment options that could improve the care of kidney transplant recipients, with a special focus on mitigating the complications that occur after transplantation.

She also assists in training future transplant nephrologists in the Washington University School of Medicine Nephrology Transplant Fellowship program. In addition to assisting with recruiting and teaching, she participates in the world renowned WUSM Nephrology Faculty band.

Seth Goldberg, MD, Assistant Professor of Medicine

Dr. Goldberg’s clinical interests are polycystic kidney disease (PKD), transplantation donor evaluation, calcium-phosphorus metabolism and bone-mineral disease, kidney stones, high blood pressure, and dialysis. As a researcher, his focus is on polycystic kidney disease (PKD), calcium-phosphorus metabolism and bone-mineral disease, and kidney stones. Dr. Goldberg is also co-director of the Nephrology Fellowship program and member of the world renowned WUSM Nephrology Faculty band.

Tingting Li, MD
Associate Professor of Medicine, Division of Nephrology
Director, Glomerular Diseases and Vasculitis Clinic

Glomerulonephritis, lupus nephritis, vasculities and amyloidosis are some of Dr. Li’s clinical interests. Dr. Li’s research focus is also upon glomerulonephritis, lupus nephritis and includes ANCA-associate vasculities and focal segmental glomerulosclerosis. Dr. Li was named Best Doctors in America, 2015-2017, by US News and World Report.